143 related articles for article (PubMed ID: 25224569)
1. The angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancer.
Okazaki M; Fushida S; Harada S; Tsukada T; Kinoshita J; Oyama K; Tajima H; Ninomiya I; Fujimura T; Ohta T
Cancer Lett; 2014 Dec; 355(1):46-53. PubMed ID: 25224569
[TBL] [Abstract][Full Text] [Related]
2. Local angiotensin II-generation in human gastric cancer: correlation with tumor progression through the activation of ERK1/2, NF-kappaB and survivin.
Kinoshita J; Fushida S; Harada S; Yagi Y; Fujita H; Kinami S; Ninomiya I; Fujimura T; Kayahara M; Yashiro M; Hirakawa K; Ohta T
Int J Oncol; 2009 Jun; 34(6):1573-82. PubMed ID: 19424575
[TBL] [Abstract][Full Text] [Related]
3. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
Suganuma T; Ino K; Shibata K; Kajiyama H; Nagasaka T; Mizutani S; Kikkawa F
Clin Cancer Res; 2005 Apr; 11(7):2686-94. PubMed ID: 15814650
[TBL] [Abstract][Full Text] [Related]
4. Protein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-β signaling pathway.
Shinbo T; Fushida S; Tsukada T; Harada S; Kinoshita J; Oyama K; Okamoto K; Ninomiya I; Takamura H; Kitagawa H; Fujimura T; Yashiro M; Hirakawa K; Ohta T
Oncol Rep; 2015 Feb; 33(2):553-8. PubMed ID: 25435013
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II promotes the progression of human gastric cancer.
Huang MM; Guo AB; Sun JF; Chen XL; Yin ZY
Mol Med Rep; 2014 Mar; 9(3):1056-60. PubMed ID: 24424956
[TBL] [Abstract][Full Text] [Related]
6. The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo.
Fujihara S; Morishita A; Ogawa K; Tadokoro T; Chiyo T; Kato K; Kobara H; Mori H; Iwama H; Masaki T
Oncotarget; 2017 Jan; 8(5):8536-8549. PubMed ID: 28052030
[TBL] [Abstract][Full Text] [Related]
7. Tgf-beta1 induced by high glucose is controlled by angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker on cultured human peritoneal mesothelial cells.
Kyuden Y; Ito T; Masaki T; Yorioka N; Kohno N
Perit Dial Int; 2005; 25(5):483-91. PubMed ID: 16178483
[TBL] [Abstract][Full Text] [Related]
8. Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast.
Saito H; Fushida S; Harada S; Miyashita T; Oyama K; Yamaguchi T; Tsukada T; Kinoshita J; Tajima H; Ninomiya I; Ohta T
Gastric Cancer; 2018 Jan; 21(1):55-67. PubMed ID: 28540637
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer.
Chen X; Meng Q; Zhao Y; Liu M; Li D; Yang Y; Sun L; Sui G; Cai L; Dong X
Cancer Lett; 2013 Jan; 328(2):318-24. PubMed ID: 23092556
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II type 1 receptor antagonist enhances cis-dichlorodiammineplatinum-induced cytotoxicity in mouse xenograft model of bladder cancer.
Kosugi M; Miyajima A; Kikuchi E; Kosaka T; Horiguchi Y; Murai M; Oya M
Urology; 2009 Mar; 73(3):655-60. PubMed ID: 19167032
[TBL] [Abstract][Full Text] [Related]
11. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
[TBL] [Abstract][Full Text] [Related]
12. Candesartan inhibits inflammation through an angiotensin II type 1 receptor independent way in human embryonic kidney epithelial cells.
Yu Y; Jiang H; Niu Y; Zhang X; Zhang Y; Liu XI; Qi T; Yu C
An Acad Bras Cienc; 2019; 91(2):e20180699. PubMed ID: 31038541
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II receptor blocker provides pancreatic beta-cell protection independent of blood pressure lowering in diabetic db/db mice.
Shao JQ; Iwashita N; Du H; Wang YT; Wang YY; Zhao M; Wang J; Watada H; Kawamori R
Acta Pharmacol Sin; 2007 Feb; 28(2):246-57. PubMed ID: 17241528
[TBL] [Abstract][Full Text] [Related]
14. Effect of an angiotensin-II type-1 receptor blocker, candesartan on hepatic fibrosis in chronic hepatitis C: a prospective study.
Ueki M; Koda M; Shimizu T; Mitsuta A; Yamamoto T; Murawaki Y
Hepatogastroenterology; 2009; 56(93):1100-4. PubMed ID: 19760950
[TBL] [Abstract][Full Text] [Related]
15. Candesartan antagonizes pressure overload-evoked cardiac remodeling through Smad7 gene-dependent MMP-9 suppression.
Yu H; Zhao G; Li H; Liu X; Wang S
Gene; 2012 Apr; 497(2):301-6. PubMed ID: 22326534
[TBL] [Abstract][Full Text] [Related]
16. Involvement of angiotensin II type 1 receptor on pathological remodeling and dysfunction in obstructed bladder.
Aikawa K; Sakai T; Ishibashi K; Shiomi H; Sagawa K; Kumagai S; Kataoka M; Akaihata H; Yamaguchi O
Int J Urol; 2012 May; 19(5):457-64. PubMed ID: 22320898
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker synergistically suppresses chronic pancreatitis in rats.
Yamada T; Kuno A; Ogawa K; Tang M; Masuda K; Nakamura S; Ando T; Okamoto T; Ohara H; Nomura T; Joh T; Shirai T; Itoh M
J Pharmacol Exp Ther; 2005 Apr; 313(1):36-45. PubMed ID: 15608084
[TBL] [Abstract][Full Text] [Related]
18. Candesartan attenuates angiogenesis in hepatocellular carcinoma via downregulating AT1R/VEGF pathway.
Fan F; Tian C; Tao L; Wu H; Liu Z; Shen C; Jiang G; Lu Y
Biomed Pharmacother; 2016 Oct; 83():704-711. PubMed ID: 27470571
[TBL] [Abstract][Full Text] [Related]
19. The role of human peritoneal mesothelial cells in the fibrosis and progression of gastric cancer.
Tsukada T; Fushida S; Harada S; Yagi Y; Kinoshita J; Oyama K; Tajima H; Fujita H; Ninomiya I; Fujimura T; Ohta T
Int J Oncol; 2012 Aug; 41(2):476-82. PubMed ID: 22614335
[TBL] [Abstract][Full Text] [Related]
20. Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats.
Yamada T; Kuno A; Masuda K; Ogawa K; Sogawa M; Nakamura S; Ando T; Sano H; Nakazawa T; Ohara H; Nomura T; Joh T; Itoh M
J Pharmacol Exp Ther; 2003 Oct; 307(1):17-23. PubMed ID: 12944495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
